2nd Anti-Fibrotic Drug Development Summit (AFDD)
November 27 - 29, 2018 - Cambridge MA USHanson Wade
info@hansonwade.com
Phone:+16174554188
AFDD (Anti-Fibrotic Drug Development) is the industry definitive fibrosis forum for drug developers focused on organ specific indications to gain cross-disciplinary insights into the next generation of candidates. Join fibrosis leaders as they address challenges in anti-fibrotic drug development through a tighter lens. Critically review demonstrating clinically meaningful anti-fibrotic activity, innovations in preclinical modalities recapitulating fibrosis, and mechanisms of action of emerging candidates. You'll hear from 24 stakeholders including GSK, Janssen and Celgene as this forum equips you with the connections and actionable insights you need to advance your anti fibrotic pipeline.